WDR35 Gene Cranioectodermal Dysplasia Type 2 Genetic Test
At DNA Labs UAE, we offer the WDR35 Gene Cranioectodermal Dysplasia Type 2 Genetic Test to diagnose this rare genetic disorder. Cranioectodermal dysplasia type 2 (CED2) is characterized by abnormalities in the development of the head, face, and limbs, along with intellectual disability and other health issues.
Test Components and Price
The WDR35 Gene Cranioectodermal Dysplasia Type 2 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Method and Test Type
The test utilizes NGS (Next-Generation Sequencing) technology, which enables the simultaneous analysis of multiple genes or even the entire genome. This high-throughput sequencing method allows for the quick and efficient sequencing of large amounts of DNA. The test falls under the dysmorphology category.
Doctor and Test Department
The WDR35 Gene Cranioectodermal Dysplasia Type 2 Genetic Test is conducted under the supervision of a qualified pediatrician in our Genetics Test Department.
Pre Test Information
Before undergoing the WDR35 Gene Cranioectodermal Dysplasia Type 2 NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the WDR35 Gene Cranioectodermal Dysplasia Type 2 NGS Genetic DNA Test gene (WDR35).
Test Details
The WDR35 gene is associated with Cranioectodermal Dysplasia Type 2 (CED2). NGS genetic testing is employed to identify mutations or variants in the WDR35 gene, aiding in diagnosis, understanding the specific genetic cause of the condition, and assisting in genetic counseling and family planning.
It is crucial to note that genetic testing for CED2 or any other genetic disorder should always be performed by a qualified healthcare professional or genetic counselor. These experts possess the knowledge and expertise to interpret the test results accurately and provide appropriate guidance and support.
| Test Name | WDR35 Gene Cranioectodermal dysplasia type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for WDR35 Gene Cranioectodermal dysplasia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WDR35 Gene Cranioectodermal dysplasia type 2 NGS Genetic DNA Test gene WDR35 |
| Test Details | The WDR35 gene is associated with a condition called cranioectodermal dysplasia type 2 (CED2). CED2 is a rare genetic disorder characterized by abnormalities in the development of the head, face, and limbs, as well as intellectual disability and other health issues. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technologies to quickly and efficiently sequence large amounts of DNA. In the context of CED2, NGS genetic testing can be used to identify mutations or variants in the WDR35 gene that may be causing the disorder. This can help with diagnosis, provide information about the specific genetic cause of the condition, and assist in genetic counseling and family planning. It’s important to note that genetic testing for CED2 or any other genetic disorder should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |
